H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH trifluoroacetate salt
Modify Date: 2024-01-11 11:01:39
H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH trifluoroacetate salt structure
|
Common Name | H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 204931-32-8 | Molecular Weight | 1024.125 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 1480.8±65.0 °C at 760 mmHg | |
| Molecular Formula | C45H73N11O16 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 849.3±34.3 °C | |
Use of H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH trifluoroacetate saltVLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD)[1]. |
| Name | H-Val-Leu-His-Asp-Asp-Leu-Leu-Glu-Ala-OH trifluoroacetate salt |
|---|---|
| Synonym | More Synonyms |
| Description | VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 1480.8±65.0 °C at 760 mmHg |
| Molecular Formula | C45H73N11O16 |
| Molecular Weight | 1024.125 |
| Flash Point | 849.3±34.3 °C |
| Exact Mass | 1023.523682 |
| LogP | 1.68 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.552 |
| L-Alanine, L-valyl-L-leucyl-L-histidyl-L-α-aspartyl-L-α-aspartyl-L-leucyl-L-leucyl-L-α-glutamyl- |
| L-Valyl-L-leucyl-L-histidyl-L-α-aspartyl-L-α-aspartyl-L-leucyl-L-leucyl-L-α-glutamyl-L-alanine |